Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
PACB Pacific Biosciences of California, Inc. daily Stock Chart
PACB [NASD]
Pacific Biosciences of California, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-0.55 Insider Own2.50% Shs Outstand167.02M Perf Week-19.21%
Market Cap442.60M Forward P/E- EPS next Y-0.56 Insider Trans-15.90% Shs Float146.61M Perf Month-28.57%
Income-84.10M PEG- EPS next Q-0.15 Inst Own85.30% Short Float14.51% Perf Quarter-49.62%
Sales90.90M P/S4.87 EPS this Y27.30% Inst Trans0.06% Short Ratio7.58 Perf Half Y-48.14%
Book/sh0.36 P/B7.36 EPS next Y6.70% ROA-51.80% Target Price6.00 Perf Year-63.95%
Cash/sh0.29 P/C9.01 EPS next 5Y30.00% ROE-121.70% 52W Range2.20 - 7.50 Perf YTD-48.44%
Dividend- P/FCF- EPS past 5Y10.10% ROI-142.00% 52W High-64.67% Beta1.86
Dividend %- Quick Ratio1.40 Sales past 5Y8.40% Gross Margin38.00% 52W Low20.45% ATR0.42
Employees404 Current Ratio1.60 Sales Q/Q43.10% Oper. Margin- RSI (14)38.27 Volatility13.97% 15.14%
OptionableYes Debt/Eq0.29 EPS Q/Q99.70% Profit Margin-92.60% Rel Volume0.53 Prev Close2.89
ShortableYes LT Debt/Eq0.00 EarningsMay 07 AMC Payout- Avg Volume2.80M Price2.65
Recom2.40 SMA20-13.79% SMA50-30.44% SMA200-46.55% Volume1,484,245 Change-8.30%
Mar-09-20Resumed Cantor Fitzgerald Overweight $5
Oct-15-19Upgrade Piper Jaffray Neutral → Overweight $8
Apr-02-19Downgrade Stephens Overweight → Equal-Weight $4.50 → $8
Oct-19-18Initiated Cowen Outperform
Nov-03-17Downgrade First Analysis Sec Overweight → Equal-Weight $4
Sep-28-17Downgrade CL King Buy → Neutral
Nov-03-16Reiterated Cantor Fitzgerald Buy $18 → $15
Jun-27-16Initiated CL King Buy
Apr-15-16Initiated First Analysis Sec Overweight $11
Feb-04-16Downgrade Piper Jaffray Overweight → Neutral
Jan-04-16Reiterated Cantor Fitzgerald Buy $11 → $18
Oct-23-15Upgrade Piper Jaffray Neutral → Overweight
Aug-27-15Initiated Cantor Fitzgerald Buy
Feb-04-15Reiterated Maxim Group Buy $10 → $11
Sep-26-13Reiterated Maxim Group Buy $4 → $8
Jan-14-13Reiterated Maxim Group Buy $3 → $4
Apr-19-11Initiated William Blair Mkt Perform
Mar-17-11Initiated Oppenheimer Perform $15
Dec-06-10Initiated Deutsche Bank Buy $18
Mar-18-20 01:52PM  Statement on Jury Verdict in Delaware Trial Against Oxford Nanopore Technologies GlobeNewswire -13.55%
Mar-07-20 11:31AM  Why Is Pacific Biosciences (PACB) Down 18.1% Since Last Earnings Report? Zacks
Mar-05-20 06:00PM  Christian Henry Appointed Chairman of Pacific Biosciences Board of Directors GlobeNewswire
Feb-25-20 05:40PM  Larry Robbins' Top 6 4th-Quarter Buys in Health Care GuruFocus.com
07:30AM  Pacific Biosciences to Support Sequencing of California Species for the Earth BioGenome Project GlobeNewswire
Feb-11-20 10:22AM  Edited Transcript of PACB earnings conference call or presentation 6-Feb-20 9:30pm GMT Thomson Reuters StreetEvents
Feb-08-20 06:53PM  Coronavirus update: At least 724 deaths, WHO to send mission, American dies in China MarketWatch
Feb-07-20 04:03PM  Pacific Biosciences Announces Retirement of Michael Phillips, SVP of Research and Development GlobeNewswire -6.12%
07:33AM  Pacific Biosciences (PACB) Reports Break-Even Earnings in Q4 Zacks
Feb-06-20 06:25PM  Pacific Biosciences of California (PACB) Reports Break-Even Earnings for Q4 Zacks
04:02PM  Pacific Biosciences Announces Fourth Quarter and Annual 2019 Financial Results GlobeNewswire
02:30PM  Pacific Biosciences of California, Inc. to Host Earnings Call ACCESSWIRE
Jan-30-20 12:31PM  Pacific Biosciences of California (PACB) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Jan-27-20 05:21AM  Big Tech Gets Put on Guard by Antitrust Police Bloomberg
Jan-21-20 02:16PM  Pacific Biosciences of California, Inc. Fourth Quarter 2019 Financial Results Call GlobeNewswire
Jan-03-20 03:34PM  Sequencing giant Illumina scraps $1.2 billion PacBio acquisition American City Business Journals
02:11AM  U.S. Kills Iranian General, Oil Prices Surge, FOMC to Release Minutes - 5 Things You Must Know Friday TheStreet.com
02:05AM  U.S. Kills Iranian General, Oil Prices Surge, FOMC to Release Minutes - 5 Things You Must Know Friday TheStreet.com
Jan-02-20 11:58PM  Illumina and Pacific Biosciences call off merger Financial Times
05:23PM  Illumina and Pacific Biosciences Call Off $1.2 Billion Deal Bloomberg
04:44PM  Illumina, Pacific Biosciences drop $1.2 billion merger agreement MarketWatch
04:05PM  Illumina and Pacific Biosciences Announce Termination of Merger Agreement Business Wire
Dec-30-19 08:31AM  Here's Why You Should Retain Pacific Biosciences Stock Now Zacks
Dec-18-19 10:05AM  Pacific Biosciences stock falls on FTC challenge to Illumina deal MarketWatch
07:23AM  The Daily Biotech Pulse: Positive Adcom Verdict For Merck, Homology Medicine Slips On Mixed Gene Therapy Efficacy Data Benzinga
Dec-07-19 12:26PM  Hedge Funds Have Never Been This Bullish On Pacific Biosciences of California, Inc. (PACB) Insider Monkey
11:31AM  Pacific Biosciences (PACB) Up 2.7% Since Last Earnings Report: Can It Continue? Zacks
Nov-25-19 08:01AM  Here's Why You Should Hold on to Pacific Biosciences Stock Zacks
Nov-20-19 08:39AM  Options Traders Expect Huge Moves in Pacific Biosciences (PACB) Stock Zacks +11.21%
07:14AM  Pacific Biosciences (PACB) Q3 Loss Wider Than Estimates Zacks
Nov-07-19 06:55PM  Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates Zacks
04:01PM  Pacific Biosciences of California, Inc. Announces Third Quarter 2019 Financial Results GlobeNewswire
Oct-31-19 10:34AM  Will Pacific Biosciences of California (PACB) Report Negative Q3 Earnings? What You Should Know Zacks
Oct-28-19 12:39PM  Hedge Funds Have Never Been More Bullish On Pacific Biosciences of California, Inc. (PACB) Insider Monkey
Oct-10-19 07:30AM  Highly Accurate SMRT Sequencing for Human Genetics to Be Showcased at ASHG 2019 Annual Meeting GlobeNewswire
Sep-18-19 09:59AM  Here's Why You Should Retain Pacific Biosciences For Now Zacks
Sep-05-19 09:31AM  Why Is Pacific Biosciences (PACB) Up 0.2% Since Last Earnings Report? Zacks
Sep-04-19 07:00AM  Merger or Not, Pacific Biosciences Needs to Deliver Motley Fool
Aug-09-19 08:54AM  Pacific Biosciences (PACB) Beats on Q2 Earnings & Revenues Zacks
Aug-06-19 06:35PM  Pacific Biosciences of California (PACB) Reports Q2 Loss, Tops Revenue Estimates Zacks
Jul-25-19 10:33AM  Analysts Estimate Pacific Biosciences of California (PACB) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-22-19 10:06AM  What Happens If Pacific Biosciences Isn't Acquired By Illumina? Motley Fool
Jul-19-19 04:34PM  Why J.C. Penney, QEP Resources, and Pacific Biosciences Slumped Today Motley Fool -9.35%
12:13PM  Here's Why Pacific Biosciences Is Tumbling Today Motley Fool
Jul-04-19 06:09PM  Why Illumina Stock Jumped 20% in June Motley Fool
Jun-21-19 10:42AM  The Zacks Analyst Blog Highlights: Invitae, Illumina, Pacific Biosciences and Guardant Health Zacks
Jun-19-19 09:31PM  Heres What Hedge Funds Think About Pacific Biosciences of California, Inc. (PACB) Insider Monkey
06:41PM  46 and You: Genetic Testing = Giant Growth Market Zacks
Jun-18-19 10:09AM  Pacific Bio Shares Fall on U.K. Antitrust Concern About Illumina Deal TheStreet.com
Jun-13-19 07:30AM  Highly Accurate Long-Read Sequencing of Human Genomes Leads to Discovery of Disease-Causing Variants GlobeNewswire
Jun-02-19 09:30AM  Pacific Biosciences (PACB) Down 7.8% Since Last Earnings Report: Can It Rebound? Zacks
May-07-19 08:01AM  Pacific Biosciences (PACB) Incurs Loss in Q1, Revenues Fall Zacks
May-03-19 04:01PM  Pacific Biosciences of California, Inc. Announces First Quarter 2019 Financial Results GlobeNewswire
May-02-19 04:17PM  Heres What Hedge Funds Think About Pacific Biosciences of California, Inc. (PACB) Insider Monkey
Apr-24-19 10:33AM  Will Pacific Biosciences of California (PACB) Report Negative Q1 Earnings? What You Should Know Zacks
07:30AM  Pacific Biosciences Launches New Sequel II System, Featuring ~8 Times the DNA Sequencing Data Output GlobeNewswire
Apr-23-19 12:14PM  Nancy Havens Havens Advisors Return, AUM, and Holdings (Part II) Insider Monkey
Apr-20-19 02:00PM  Pump the Brakes on the Illumina and Pacific Biosciences Deal Motley Fool
Apr-02-19 07:30AM  Transplant Matches Identified by Ultra-High-Resolution HLA Typing Associated with Higher Patient Survival Rates GlobeNewswire
Mar-13-19 09:30AM  Pacific Biosciences (PACB) Up 3.8% Since Last Earnings Report: Can It Continue? Zacks
Feb-26-19 07:30AM  Latest PacBio Sequencing Advancements Including Preview of Sequel II System to be Featured at Annual AGBT Conference GlobeNewswire
Feb-18-19 05:53PM  Prem Watsa Buys 7 Stocks in 4th Quarter GuruFocus.com
Feb-12-19 10:01AM  Pacific Biosciences (PACB) Incurs Q4 Loss, Revenues Fall Y/Y Zacks
Feb-11-19 06:20PM  Pacific Biosciences of California (PACB) Reports Q4 Loss, Lags Revenue Estimates Zacks
05:23PM  Pacific Biosciences: 4Q Earnings Snapshot Associated Press
04:01PM  Pacific Biosciences Announces Fourth Quarter and Annual 2018 Financial Results GlobeNewswire
Feb-03-19 09:00AM  5 Things to Expect From Illumina in 2019 Motley Fool
Jan-31-19 10:31AM  Pacific Biosciences of California (PACB) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Jan-17-19 07:40AM  Report: Exploring Fundamental Drivers Behind SkyWest, Pacific Biosciences of California, Lennar, Regeneron Pharmaceuticals, MGM Growth Properties, and Cincinnati Bell New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Jan-04-19 08:27AM  LMNX or PACB: Which is a Better MedTech Investment Pick? Zacks
Dec-31-18 10:51AM  Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Red Hat, LSC Communications, Intersections, and Pacific Biosciences on Behalf of Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
Dec-18-18 03:40PM  INVESTOR ALERT: Monteverde & Associates PC Is Investigating The Acquisition Of Pacific Biosciences of California, Inc. Scheduled For A Shareholder Vote On January 24, 2019 PACB ACCESSWIRE
Dec-12-18 11:55PM  Wolf Haldenstein Adler Freeman & Herz LLP announces that it has filed a class action complaint in the United States District Court for the Northern District of California on behalf of holders of Pacific Biosciences of California, Inc. GlobeNewswire
Dec-10-18 05:06PM  Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Pacific Biosciences of California, Inc. (PACB) on Behalf of Stockholders and Encourages PACB Investors to Contact the Firm GlobeNewswire
Dec-07-18 02:04PM  PACIFIC BIOSCIENCES OF CALIFORNIA, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout Business Wire
Dec-06-18 09:39PM  SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Pacific Biosciences of California, Inc. - PACB PR Newswire
08:44AM  Here's Why You Should Hold Pacific Biosciences (PACB) Now Zacks
Nov-16-18 08:35AM  Here's Why You Should Invest in Illumina (ILMN) Stock Now Zacks
Nov-15-18 10:02AM  Pacific Biosciences Offers Insights on Aedes aegypti Genome Zacks
Nov-14-18 02:26PM  Is This the Real Reason Illumina Acquired Pacific Biosciences? Motley Fool
01:00PM  PacBios SMRT Sequencing Provides Unprecedented Insight into Genome of Disease-causing Mosquito GlobeNewswire
Nov-12-18 07:05AM  Pacific Biosciences Agrees to be Acquired in an All Cash Transaction, Analysts Review ACCESSWIRE
Nov-08-18 04:55PM  Why Alkermes' Depression Drug Stumbled, and How Illumina Plans to Profit From M&A Motley Fool
Nov-07-18 10:09AM  Pacific Biosciences (PACB) Reports Q3 Loss, Revenues Fall Y/Y Zacks
09:34AM  Illumina (ILMN) Inks $1.2B Deal to Buy Pacific Biosciences Zacks
07:45AM  Consolidated Research: 2018 Summary Expectations for Pacific Biosciences of California, NXP Semiconductors N.V., Consolidated Communications, Alexander & Baldwin, Willdan Group, and OneMain Fundamental Analysis, Key Performance Indications GlobeNewswire
Nov-06-18 09:30AM  Big Biotech May Be After These Technologies ACCESSWIRE
Nov-03-18 02:01PM  Here's Why Illimuna Just Bought Its Biggest Competitor Motley Fool
Nov-02-18 04:47PM  Apple and Kraft Heinz drop while Starbucks and Symantec rise Associated Press +67.63%
04:28PM  Why Newell Brands, VeriSign, and Pacific Biosciences of California Jumped Today Motley Fool
11:00AM  Why Pacific Biosciences of California Stock Is Skyrocketing Today Motley Fool
10:30AM  Surge In Healthcare Growth Sees Rally In These 3 Stocks On Friday ACCESSWIRE
08:32AM  Illumina Buys Rival Pacific Biosciences In $1.2B Deal Benzinga
08:01AM  The Daily Biotech Pulse: Illumina Snaps Up Pacific Bioscience, Thumbs Down For Alkermes Depressive Disorder Drug Benzinga
07:30AM  Pacific Biosciences of California (PACB) Reports Q3 Loss, Lags Revenue Estimates Zacks
06:01AM  Pacific Biosciences of California Reports a Dismal Quarter -- and a Delightful Acquisition Motley Fool
05:13AM  Pacific Biosciences: 3Q Earnings Snapshot Associated Press
Nov-01-18 05:49PM  Illumina Inc. to buy Menlo Park-based biotech firm for $1.2 billion American City Business Journals
05:07PM  Illumina to buy rival Pacific Biosciences in $1.2 bln deal Reuters
04:18PM  Gene sequencing company Illumina to buy Pacific Biosciences in $1.2 billion deal Reuters
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company's single molecule real-time (SMRT) sequencing technology enables single molecule real-time detection of biological processes. It offers PacBio RS II and Sequel Systems that conducts, monitors, and analyzes single molecule biochemical reactions in real time. The company also provides consumable products, including SMRT cells, as well as various reagent kits, such as template preparation, binding, and sequencing kits. Its customers include research institutions; commercial laboratories; genome centers; clinical, government, and academic institutions; genomics service providers; pharmaceutical companies; and agricultural companies. The company markets its products through a direct sales force in North America and Europe, as well as primarily through distribution partners in Asia, the Middle East, Africa, and Latin America. The company was formerly known as Nanofluidics, Inc. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Phillips James MichaelSVP, Research & DevelopmentMar 24Sale3.052,7608,421249,220Mar 24 06:12 PM
Phillips James MichaelSVP, Research & DevelopmentFeb 20Sale4.485,05022,624251,980Feb 24 05:55 PM
Hunkapiller MichaelChairman, CEO & PresidentFeb 20Sale4.50166,575749,7541,868,395Feb 24 04:15 PM
BARNES SUSAN KEVP, CFO and PAOFeb 19Sale4.4412,55855,758874,812Feb 25 07:09 PM
Hunkapiller MichaelChairman, CEO & PresidentFeb 19Sale4.4976,281342,3492,034,970Feb 20 05:33 PM
Hunkapiller MichaelChairman, CEO & PresidentFeb 18Sale4.49525,9952,363,2962,111,251Feb 20 05:33 PM
open in yahoo | open in reuters | open in google